Solvay S.A.

Solvay is engaged in chemical and plastic businesses worldwide. Co. offers chemical products such as advanced materials, barium strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as Spire ultra polymers, Solviva biomaterials, and sulfone polymers. Co. structures its activities around five operating segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers and Corporate & Business Services, each with its own specific business model and each comprised of Global Business Units (GBUs).
  • TickerSOLB
  • ISINBE0003470755
  • ExchangeEuronext Brussels
  • SectorChemicals
  • CountryBelgium
Joachim Vansanten ...
  • Wim Hoste

Morning Note: SOLB BB, TINC BB

Solvay: Partnership with Veolia to treat end-of-life batteries TINC: FY19/20: Steady portfolio growth

ING
ING Helpdesk

Benelux Morning Notes

ASM International : Feedback from management call. B&S Group: The Hut Group - intention to float. Solvay: Enters into Li-ion battery recycling with Veolia. Staffing sector: French data - July recovers, August outlook indicates further recovery.

ING
ING Helpdesk

Benelux Morning Notes

ING Benelux Conference highlights. Other news: Ageas: Takeover attempt unsuccessful from the go? ASML: Feedback from roadshow. Econocom: close to buying French maritime salvage company Les Abeilles. Sioen Industries: Impressive 1H20 but visibility on full year remains limited

Jérôme VINERIER

Short term view - SOLVAY : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €98.38. The background trend would be questioned should prices rise above €119.00.

Jérôme VINERIER

Analyse court terme - SOLVAY : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 98,38 €. La tendance de fond serait remise en cause en cas de franchissement de 119,00 €.

Jérôme VINERIER

Analyse court terme - SOLVAY : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 98,38 €, puis 94,15 €. Le franchissement de 119,00 € remettrait en cause la suite de la baisse.

Jérôme VINERIER

Short term view - SOLVAY : The background trend is clearly bearish.

The background trend is clearly bearish. The movement goes on. The next target is at €98.38, then €94.15. Passing €119.00 would question the continuation of the fall.

Jérôme VINERIER

Analyse moyen terme - SOLVAY : La tendance est baissière.

La tendance est baissière. Le mouvement se poursuit. Le prochain objectif est à 90,40 €, puis 74,62 €. Le franchissement de 118,58 € remettrait en cause la suite de la baisse.

Joachim Vansanten ...
  • Wim Hoste

Morning Note: SOLB BB, TINC BB

Solvay: Partnership with Veolia to treat end-of-life batteries TINC: FY19/20: Steady portfolio growth

ING
ING Helpdesk

Benelux Morning Notes

ASM International : Feedback from management call. B&S Group: The Hut Group - intention to float. Solvay: Enters into Li-ion battery recycling with Veolia. Staffing sector: French data - July recovers, August outlook indicates further recovery.

ING
ING Helpdesk

Benelux Morning Notes

ING Benelux Conference highlights. Other news: Ageas: Takeover attempt unsuccessful from the go? ASML: Feedback from roadshow. Econocom: close to buying French maritime salvage company Les Abeilles. Sioen Industries: Impressive 1H20 but visibility on full year remains limited

Guy Sips ...
  • Jason Kalamboussis
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs
  • Wim Hoste

Morning Note: AGFB BB, ASRNL NA, BOTHE BB, EVS BB, GLPG NA, MDXH BB, REC BB, SOLB BB

Agfa: € 350m to increase funding ratio of pension plans ASR: 2Q above, increase TP, but prefer NN Group Bone Therapeutics: 1H20 results – resuming clinical activities EVS: 1H20 preview as market conditions are challenging Galapagos: Filgotinot so fast: changes post CRL MDxHealth: Operational improvements despite strong headwind Recticel: Preview 1H: expect uninspiring results Solvay: Refinancing of hybrids

Emmanuel Matot

ODDO : Arkema more optimistic over recovery than Solvay

>Arkema: Q2 results less bad than expected and signs of improvement in demand - Following the release of Arkema's Q2 results on Thursday, we would note a 30% drop in EBITDA to € 286m (consensus = € 261m), hard hit by weak demand amid a severe health crisis, with volumes down 12% and transport, industry and construction particularly affected. Specialty Materials held up better (EBITDA down 23%) compared to Intermediates (EBITDA down 48%).Regarding prospects, we wo...

Carole Braudeau

Accor : Credit Feedback – Oddo BHF Forum 10 and 11 January

Our annual Forum in Lyon brought together 263 companies, including 41% of foreign companies, nearly 545 investors (33% foreigners), almost 6,500 one-to-one meetings. - This document gathers a brief feedback from the bond issuers and CB underlying companies in attendance. - - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties, Icade, JCDecaux, Klépierre, Lanxess, MT...

Carole Braudeau

Accor : Feedback Crédit Forum des 10 et 11 janvier 2019

Notre Forum annuel Oddo BHF 2019 vient de se dérouler à Lyon : il a réuni 263 sociétés, dont 41% étrangères, près de 545 investisseurs (33% étrangers), soit près de 6 500 one-to-one. - Ce document synthétise nos feed-back concernant les émetteurs obligataires présents et sous-jacents d’obligations convertibles. - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties,...

Solvay SA - December 2016 (LTM): Peer Snapshot

Peer Snapshot: Solvay SA - December 2016 (LTM) 13 April 2017 (in US millions) FYE Dec-14 FYE Dec-15 LTM Dec-16 FYE Dec-14 FYE Dec-15 LTM Sep-16 FYE Dec-14 FYE Dec-15 LTM Dec-16

Bruno Cavalier ...
  • Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 08/03/2020

...

Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 08/03/2020

...

Bruno Cavalier ...
  • Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 03/08/2020

...

Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 03/08/2020

...

SOLVAY SA sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of SOLVAY SA (BE), a company active in the Speciality Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date June 19, 2020, the closing price was EUR 74.20 and its potential was estimated at EUR 86.80.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the we...

Expert Corporate Governance Service (ECGS)

Solvay – AGM 12 May 2020

Resolution 2: Ilham Kadri's total compensation amounts to €5,321,151 (including compensation for loss of compensation from previous employment and relocation expenses), i.e. 195% of the median of total compensation of SBF120 executives. It should be noted that she took over the management of the Group on 1 March 2019, which corresponds to only 10 months of presence for the 2019 financial year.   Resolution 4: Concerning the allocation of the result, despite a distribution rate of 326%, this is due to the impairment of € 825 million recorded during the 2019 financial year. Even though this ch...

Pierre-Antoine Bourgoin

Solvay - Assemblée Générale du 12 mai 2020

La rémunération totale d'Ilham Kadri s'élève à 5 321 151 € (comprenant une indemnité pour la perte de rémunération d'un emploi antérieur et les frais de relocalisation), soit 195% de la médiane des rémunérations totales des dirigeants du SBF120. Elle représente 255 SMICs, ce qui excède notre plafond de 240 SMICs. Précisons qu'elle n'a repris la direction du Groupe que le 1er mars 2019, ce qui correspond à seulement 10 mois de présence au titre de l'exercice 2019. Concernant l'affectation du résultat, malgré un taux de distribution de 326%, celui-ci est à relativiser en raison de la dépréciati...

Pauline Delecourt

SOLVAY - Assemblée Générale Extraordinaire des actionnaires du 3 avril 2020

La société propose de renouveler deux autorisations (résolutions 1 et 2) pour une durée de 5 ans. Proxinvest note que dans la nouvelle rédaction de l’article 8 (résolution 2), la société ne prévoit plus la possibilité d’utiliser cette délégation en période d’OPA, ce que Proxinvest félicite. De plus, il est proposé de moderniser les anciens statuts (résolutions 3 et 4) et de les aligner sur les pratiques actuelles. Afin d’aligner les statuts sur le « CAC » (Companies and Associations Code) et de simplifier et moderniser certaines dispositions, il est proposé de remplacer le texte actuel des a...

Expert Corporate Governance Service (ECGS)

Solvay - EGM 3 april 2020

ITEMS 1 and 2: the Company seeks shareholder approval to renew two authorizations for a period of 5 years. ECGS notes that the new text of article 8 (ITEM 2) does not allow the company to use its authorization during a takeover bid anymore. Both authorizations respect ECGS’ guidelines and we recommend shareholders to approve. ITEMS 3 and 4: the Company seeks shareholder approval to align the articles of association with the CAC (Companies and Associations Code), and simplify and modernize certain provisions. Consequently, it is proposed to replace the current text of the articles of associati...

Expert Corporate Governance Service (ECGS)

Solvay - AGM 14 May 2019

This year, the company had an important management change. Indeed, Jean-Pierre Clamadieu resigned from his position as CEO and is replaced by Ilham Kadri. The new CEO will be proposed to the board along with two re-appointments. We regret that the Company continues to grant stock options without performance conditions, even if it is allegedly justified by the fact that the company is Belgian.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch